54.09 +1.25 (2.32%)
BIIB
Stock Details
Last Trade:54.09 Change:+1.25 (2.32%) Prev Close:52.84 Open: 53.88 Days Range:53.33 – 54.88 52 Week Range: 5.93 - 55.37 Volume:2964960 P/E: 18.15EPS:2.98
View AllRecent Alerts 02/09/10
Recent Alert on 02/09/10 at 8:51am
Biogen Idec (BIIB) Reports Solid Q4 Profits and Provides Better-than-Expected Outlook
Biogen Idec (BIIB) Reports Solid Q4 Profits and Provides Better-than-Expected Outlook
Biogen Idec Inc. (NASDAQ: BIIB) said on Tuesday that the company's fourth-quarter earnings increased by 47.8 percent, bolstered by the strong sales of its multiple sclerosis drugs. The biotech company reported fourth-quarter earnings of $1.20... Read More
Recent Alert on 02/09/10 at 8:51am
Biogen Idec (BIIB) Reports Solid Q4 Profits and Provides Better-than-Expected Outlook
Biogen Idec (BIIB) Reports Solid Q4 Profits and Provides Better-than-Expected Outlook
Recent Alert on 02/09/10 at 7:16am
Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street
Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street
Recent Alert on 02/09/10 at 7:16am
Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street
Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street
Recent Alert on 02/09/10 at 7:16am
Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street
Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street
View AllRecent Press Releases
Press Release on 02/08/10 at 3:00pm
Multiple Sclerosis Experts Join Biogen Idec's Research and Development Team
Multiple Sclerosis Experts Join Biogen Idec's Research and Development Team
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 02/05/10 at 4:30pm
Closing Bell: The Awful Day That Wasn't So Awful (ARG, APD, JPM, CSCO, N, BIDU, BIIB)
Closing Bell: The Awful Day That Wasn't So Awful (ARG, APD, JPM, CSCO, N, BIDU, BIIB)